ウシラクトフェリンによる Clostridium perfringens の凝集および増殖抑制作用におけるリポテイコ酸の影響

2006/05/31 by Geoffrey K. Isbister, Margaret A. O’Leary, Mark Miller +9 · 4 citations
Agricultural and Biological Sciences · Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Anesthesia #Antivenom #Bacteria #Biology #Chemistry #Clostridium perfringens #Genetics #Healthcare and Venom Research #Insect and Pesticide Research #Medicine #Streptococcal Infections and Treatments #Venom #Venomous Animal Envenomation and Studies #Vial

paper · pdf · doi:10.1111/j.1365-2125.2007.03004.x

openalex publication_date 2006/05/31 · openalex created_date 2016/06/24 · openalex updated_date 2026/06/11

Abstract

RBS AV given by the intramuscular route is unlikely to be effective in the treatment of redback (widow) spider bite.

Citations

• Latrodectism: a prospective cohort study of bites by formally identified redback spiders
• Clinical consequences of spider bites: recent advances in our understanding
• Venoms, antivenoms and immunotherapy
• The black widow spider genus Latrodectus (Araneae: Theridiidae): phylogeny, biogeography, and invasion history

Cited by

• A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study
• Spider bite
• Randomized Controlled Trial of Intravenous Antivenom Versus Placebo for Latrodectism: The Second Redback Antivenom Evaluation (RAVE-II) Study
• Redback spider [wikipedia]